Villalona-Calero MA - Search Results

1

Phase I dose escalation study of KOS-1584, a novel epothilone, in patients with advanced solid tumors.

Lam ET, Goel S, Schaaf LJ, Cropp GF, Hannah AL, Zhou Y, McCracken B, Haley BI, Johnson RG, Mani S, Villalona-Calero MA. Lam ET, et al. Cancer Chemother Pharmacol. 2012 Feb;69(2):523-31. doi: 10.1007/s00280-011-1724-7. Epub 2011 Aug 27. Cancer Chemother Pharmacol. 2012. PMID: 21874318 Free PMC article. Clinical Trial.

2

Acute progranulocytic leukemia (APL): possible in vivo differentiation by granulocyte colony-stimulating factor (G-CSF).

Vaickus L, Villalona-Calero MA, Caligiuri T. Vaickus L, et al. Leukemia. 1993 Oct;7(10):1680-1. Leukemia. 1993. PMID: 7692195 No abstract available.

3

Integrating Early-Stage Drug Development with Clinical Networks; Challenges and Opportunities: The City of Hope Developing Experience.

Villalona-Calero MA, Malhotra J, Chung V, Xing Y, Gray SW, Hampel H, Gruber S, McDonnell K. Villalona-Calero MA, et al. J Clin Med. 2023 Jun 15;12(12):4061. doi: 10.3390/jcm12124061. J Clin Med. 2023. PMID: 37373756 Free PMC article.

4

Phase I and pharmacokinetic trial of oral irinotecan administered daily for 5 days every 3 weeks in patients with solid tumors.

Drengler RL, Kuhn JG, Schaaf LJ, Rodriguez GI, Villalona-Calero MA, Hammond LA, Stephenson JA Jr, Hodges S, Kraynak MA, Staton BA, Elfring GL, Locker PK, Miller LL, Von Hoff DD, Rothenberg ML. Drengler RL, et al. J Clin Oncol. 1999 Feb;17(2):685-96. doi: 10.1200/JCO.1999.17.2.685. J Clin Oncol. 1999. PMID: 10080615 Clinical Trial.

5

Phase I and pharmacologic study of the tyrosine kinase inhibitor SU101 in patients with advanced solid tumors.

Eckhardt SG, Rizzo J, Sweeney KR, Cropp G, Baker SD, Kraynak MA, Kuhn JG, Villalona-Calero MA, Hammond L, Weiss G, Thurman A, Smith L, Drengler R, Eckardt JR, Moczygemba J, Hannah AL, Von Hoff DD, Rowinsky EK. Eckhardt SG, et al. J Clin Oncol. 1999 Apr;17(4):1095-104. doi: 10.1200/JCO.1999.17.4.1095. J Clin Oncol. 1999. PMID: 10561166 Clinical Trial.

6

Phase I dose-finding and pharmacokinetic trial of irinotecan (CPT-11) administered every two weeks.

Rothenberg ML, Kuhn JG, Schaaf LJ, Rodriguez GI, Eckhardt SG, Villalona-Calero MA, Rinaldi DA, Hammond LA, Hodges S, Sharma A, Elfring GL, Petit RG, Locker PK, Miller LL, von Hoff DD. Rothenberg ML, et al. Ann Oncol. 2001 Nov;12(11):1631-41. doi: 10.1023/a:1013157727506. Ann Oncol. 2001. PMID: 11822765 Free article. Clinical Trial.

7

Phase I study of low-dose suramin as a chemosensitizer in patients with advanced non-small cell lung cancer.

Villalona-Calero MA, Wientjes MG, Otterson GA, Kanter S, Young D, Murgo AJ, Fischer B, DeHoff C, Chen D, Yeh TK, Song S, Grever M, Au JL. Villalona-Calero MA, et al. Clin Cancer Res. 2003 Aug 15;9(9):3303-11. Clin Cancer Res. 2003. PMID: 12960116 Clinical Trial.

8

A phase I/II study of LY900003, an antisense inhibitor of protein kinase C-alpha, in combination with cisplatin and gemcitabine in patients with advanced non-small cell lung cancer.

Villalona-Calero MA, Ritch P, Figueroa JA, Otterson GA, Belt R, Dow E, George S, Leonardo J, McCachren S, Miller GL, Modiano M, Valdivieso M, Geary R, Oliver JW, Holmlund J. Villalona-Calero MA, et al. Clin Cancer Res. 2004 Sep 15;10(18 Pt 1):6086-93. doi: 10.1158/1078-0432.CCR-04-0779. Clin Cancer Res. 2004. PMID: 15447994 Clinical Trial.

9

A phase I clinical and pharmacokinetic study of fenretinide combined with paclitaxel and cisplatin for refractory solid tumors.

Otterson GA, Lavelle J, Villalona-Calero MA, Shah M, Wei X, Chan KK, Fischer B, Grever M. Otterson GA, et al. Invest New Drugs. 2005 Dec;23(6):555-62. doi: 10.1007/s10637-005-1665-2. Invest New Drugs. 2005. PMID: 16034523 Clinical Trial.

10

Assessment of tumor necrosis factor alpha blockade as an intervention to improve tolerability of dose-intensive chemotherapy in cancer patients.

Monk JP, Phillips G, Waite R, Kuhn J, Schaaf LJ, Otterson GA, Guttridge D, Rhoades C, Shah M, Criswell T, Caligiuri MA, Villalona-Calero MA. Monk JP, et al. J Clin Oncol. 2006 Apr 20;24(12):1852-9. doi: 10.1200/JCO.2005.04.2838. J Clin Oncol. 2006. PMID: 16622259 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

133 results

Search Page

Filters